- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05756855
Young Adults With Violent Behavior During Early Psychosis
January 26, 2024 updated by: Stephanie A Rolin, MD, Columbia University
Young Adults With Violent Behavior During Early Psychosis: An Open Pilot Trial
This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The investigators will conduct an open pilot trial of a behavioral intervention to reduce violent behavior within the OnTrackNY network.
The focus of this open pilot is to explore the acceptability and feasibility of the intervention.
The study will enroll early intervention service (EIS) clinician - EIS participant dyads.
The planned sample size is 3-4 EIS clinicians and 10-16 EIS participants (up to n=16 dyads).
This real-world open pilot will provide feedback to help tailor the intervention to the OnTrackNY setting.
Study Type
Interventional
Enrollment (Estimated)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephanie Rolin, MD, MPH
- Phone Number: 212-305-8075
- Email: stephanie.rolin@nyspi.columbia.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- New York State Psychiatric Institute
-
Contact:
- Stephanie Rolin, MD, MPH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria for EIS participants:
- Ages 16 to 30 who have experienced nonaffective psychosis with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, other specified/unspecified schizophrenia spectrum and other psychotic disorders (International Classification of Disease Clinical Modification (ICD-10-CM) Diagnosis Code F20.x)
- Receive First Episode Psychosis (FEP) treatment in one of OnTrackNY clinics/sites with an eligible EIS clinicians
- Willing to participate in research interviews after each study visit during the study period
Exclusion Criteria:
- Unable to provide informed consent
- Not fluent (speaking, reading, writing) in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: behavioral intervention
This will involve conducting a 12-week open pilot trial (up to n=16 dyads of EIS clinicians-EIS participants) to test the feasibility and acceptability of the adapted Psychological Interventions for Coping with Anger and Schizophrenia: a study of outcomes (PICASSO) intervention in the OnTrackNY setting.
|
cognitive behavioral therapy based intervention that focuses on anger, violence, and psychosis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Acceptability of Intervention Measure (AIM)
Time Frame: 12 weeks
|
The AIM is a 4-item measure of the acceptability of the intervention, to be completed by EIS clinicians.
Scores range from 1-4 with higher score indicating high acceptability.
|
12 weeks
|
Mean Feasibility of Intervention Measure (FIM)
Time Frame: 12 weeks
|
The FIM is a 4-item measure of the feasibility of the intervention, to be completed by EIS clinicians.
Scores range from 1-4 with higher score indicating high feasibility.
|
12 weeks
|
Number of EIS Participants in Attendance
Time Frame: 12 weeks
|
The number of EIS participants that attend the cognitive behavioral therapy sessions.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephanie Rolin, MD, MPH, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2024
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
February 23, 2023
First Submitted That Met QC Criteria
February 23, 2023
First Posted (Actual)
March 6, 2023
Study Record Updates
Last Update Posted (Estimated)
January 29, 2024
Last Update Submitted That Met QC Criteria
January 26, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8451 (The Newcastle upon Tyne Hospitals NHS FT)
- K23MH126312 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Findings from this study will be presented to research peers, clinicians, and the public through Presentations at Scientific Meetings, Regional Research or Educational Meetings, Newsletters and Social Media and Peer-Reviewed Publications.
Those events will occur during or at the conclusion of the study.
IPD Sharing Time Frame
Descriptive and raw data will be submitted on an annual basis.
Unpublished de-identified data will be shared within one year after project completion, or when the data are published, whichever is earlier.
IPD Sharing Access Criteria
Data and materials will be made available for research to investigators working under a Federal Wide Assurance who meet security measures and data use agreement criteria associated with public repositories, including the National Database for Clinical Trials related to Mental Illness (NDCT) and the National Institute of Mental Health (NIMH) Database of Cognitive Training and Remediation Studies (DoCTRS).
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on adapted behavioral intervention
-
Koç UniversityCompletedPsychological Distress | Well-beingTurkey
-
Koç UniversityCompletedQuality of Life | Anxiety | Depressive Symptoms | Psychological DistressTurkey
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
RANDNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States
-
Bahria UniversityRecruitingInternet Gaming DisorderPakistan
-
Children's National Research InstitutePatient-Centered Outcomes Research Institute; George Washington UniversityRecruitingPerinatal Depression | Prenatal Stress | Perinatal AnxietyUnited States
-
University of UtahNational Institute on Drug Abuse (NIDA)Completed
-
Vanderbilt University Medical CenterCompletedDepression | Suicidal Ideation | Autism Spectrum Disorder | Self EsteemUnited States
-
Koç UniversityRecruitingDepressive Symptoms | Psychological Distress | Well-Being, PsychologicalTurkey
-
VA Office of Research and DevelopmentActive, not recruiting